Kimberly-Clark (KMB)
Maker of Huggies diapers, Kleenex tissues, Kotex feminine care, and Depend incontinence products.
Something off on this page? Send us feedback.
Manufactures diapers, training pants, feminine and incontinence care, household tissue, and workplace hygiene products under Huggies, Kotex, Depend, Kleenex, Scott, and other brands. North America generates most continuing sales, while consolidated international operations now center on personal care following the launch of the Arbex tissue and hygiene joint venture.
Manufactures diapers, training pants, feminine-care and incontinence products, household tissue, paper towels, and workplace hygiene supplies. Huggies, Pull-Ups, GoodNites, Kotex, Depend, Poise, Kleenex, Scott, Cottonelle, and WypAll reach households and institutional buyers through retailers, distributors, and e-commerce.
North America spans baby and child, adult, feminine, family, and professional care and generates most continuing sales; International Personal Care concentrates on the first three categories in selected markets. Manufacturing depends on cellulose fiber, synthetics, chemicals, and superabsorbent materials purchased from third parties. Following Arbex's launch, most international tissue and professional operations sit in a Suzano-controlled joint venture where a minority interest is retained. The pending Kenvue acquisition remains on track to close by year-end.
Company facts
Target rangeAs of Sep 22, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Sep 11, 2026 | Piper Sandler | Reiterate | Rating: —Target: $121 | Target: $118 |
| Aug 5, 2026 | UBS | Reiterate | Rating: —Target: $115 | Target: $116 |
| Aug 4, 2026 | Seaport Global | Upgrade | Rating: — | |
| Jul 21, 2026 | Barclays | Reiterate | Rating: —Target: $99 | Target: $115 |
| Jul 16, 2026 | UBS | Reiterate | Rating: —Target: $106 | Target: $115 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $956.0M · Total debt $6.52B · Total assets $18.55B · Shareholders' equity $1.75B
- Revenue
- $4.19B
- Operating income
- $448.0M
- Net income
- $345.0M
HistoryDividendAnnual yield
| Institutions | ≈ 102.45% | 340.72M shares | |
|---|---|---|---|
| 1,762 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 0.21% | 704.1K shares | |
| 16 holders · as of Sep 1, 2026 | |||
| Adds to | 102.66% | ||
332.58M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 102.66%; nothing is left for Other.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
BlackRock, Inc.Institution | 9.72% | 32.32M | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 6.51% | 21.66M | as of Jun 30, 2026 |
State Street CorpInstitution | 6.34% | 21.08M | as of Jun 30, 2026 |
Vanguard Portfolio Management LLCInstitution | 4.84% | 16.10M | as of Jun 30, 2026 |
FMR LLCInstitution | 3.95% | 13.13M | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| May 6, 2026 | Andrew Scribner | officer: Controller, VP & FP&A | −4,095 | $98.00 |
| May 4, 2026 | Katy Chen | officer: President, Int'l Personal Care | −1,596 | $95.34 |
| Apr 30, 2026 | Katy Chen | officer: President, Int'l Personal Care | −1,405 | $96.96 |
| Feb 9, 2026 | Todd Maclin | director | +10,000 | $104.15 |
| Apr 9, 2025 | Todd Maclin | director | +266 | $145.77 |
- Procter & Gamble
Dominant global rival across diapers, femcare, tissue, and adult incontinence.
- Haleon (ADR)
Global OTC consumer health leader competing on pain relief, oral care, and VMS.
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Kimberly-Clark | $98.17 | −0.75% | $32.83B | 16.8 | 14.0 | 2.0 | +0.6% |
| Procter & Gamble | $148.33 | +0.07% | $352.35B | 22.4 | 21.2 | 4.0 | +1.5% |
| Haleon (ADR) | $9.27 | +0.16% | $40.74B | 19.3 | — | 2.7 | +3.7% |
| Median | 20.9 | 21.2 | 3.4 | +2.6% |